Sign in

CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company

Enveric Biosciences, Inc.

Sign in to watch
Ticker
ENVB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954484725
Phone
(617) 444-8400
Business address
245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
Former names
AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 223 shares at $6.51 ($1,452)
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 434 shares at $6.51 ($2,825)
  5. 4 Option exercise Director acquired 17,663 shares (option exercise)
  6. 4 Option exercise Director acquired 14,245 shares (option exercise)
  7. 4 Option exercise Director acquired 16,809 shares (option exercise)
  8. 4 Option exercise Director acquired 14,245 shares (option exercise)
  9. 4 Open-market buy Director bought 2,130 shares at $6.51 ($13,866)
  10. 4 Open-market buy Director bought 10,000 shares at $6.51 ($65,100)
  11. 4 Open-market buy Director bought 40 shares at $6.51 ($260)
  12. 4 Open-market buy Director bought 1,506 shares at $6.51 ($9,804)
  13. 4 Open-market buy Director bought 700 shares at $6.51 ($4,557)
  14. 4 Open-market buy Director bought 808 shares at $6.51 ($5,260)
  15. 4 Open-market buy Director bought 526 shares at $6.51 ($3,424)
  16. 4 Open-market buy Director bought 183 shares at $6.51 ($1,191)
  17. 4 Open-market buy Director bought 18,685 shares at $6.51 ($121,639)
  18. 4 Other acquisition Exec. Vice Chairman acquired 299,250 shares (other)
  19. 4 Open-market buy Director bought 1,094 shares at $6.51 ($7,122)
  20. 4 Open-market buy Director bought 450 shares at an average $6.51 ($2,929)

Page 8 of 12 · 234 filings